BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2766 related articles for article (PubMed ID: 19120898)

  • 1. Taishotoyama Symposium Barriers to colorectal cancer screening: economics, capacity and adherence.
    Inadomi JM
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S198-204. PubMed ID: 19120898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current colorectal cancer screening strategies: overview and obstacles to implementation.
    Rex DK
    Rev Gastroenterol Disord; 2002; 2 Suppl 1():S2-11. PubMed ID: 12439393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of colorectal screening in rural Colorado: testing to prevent colon cancer in the high plains research network.
    Young WF; McGloin J; Zittleman L; West DR; Westfall JM
    J Rural Health; 2007; 23(3):238-45. PubMed ID: 17565524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of computerized tomographic colonography versus colonoscopy for colorectal cancer screening.
    Heitman SJ; Manns BJ; Hilsden RJ; Fong A; Dean S; Romagnuolo J
    CMAJ; 2005 Oct; 173(8):877-81. PubMed ID: 16217110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence with colorectal cancer screening guidelines: a review.
    Subramanian S; Klosterman M; Amonkar MM; Hunt TL
    Prev Med; 2004 May; 38(5):536-50. PubMed ID: 15066356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns and predictors of colorectal cancer test use in the adult U.S. population.
    Seeff LC; Nadel MR; Klabunde CN; Thompson T; Shapiro JA; Vernon SW; Coates RJ
    Cancer; 2004 May; 100(10):2093-103. PubMed ID: 15139050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is virtual colonoscopy a cost-effective option to screen for colorectal cancer?
    Sonnenberg A; Delcò F; Bauerfeind P
    Am J Gastroenterol; 1999 Aug; 94(8):2268-74. PubMed ID: 10445561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Individual screening for colorectal cancer: which strategy for which patient?].
    Demols A; Van Laethem JL; Gay F; Franchimont D; Adler M; Van Gossum A
    Rev Med Brux; 2001 Sep; 22(4):A203-9. PubMed ID: 11680174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization of colorectal cancer screening tests: a 1997 survey of Massachusetts internists.
    Schroy PC; Geller AC; Crosier Wood M; Page M; Sutherland L; Holm LJ; Heeren T
    Prev Med; 2001 Nov; 33(5):381-91. PubMed ID: 11676578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for colorectal cancer on the front line.
    Lemon SC; Zapka JG; Estabrook B; Erban S; Luckmann R
    Am J Gastroenterol; 2003 Apr; 98(4):915-23. PubMed ID: 12738477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for colorectal cancer: the cost to find an advanced adenoma.
    McGrath JS; Ponich TP; Gregor JC
    Am J Gastroenterol; 2002 Nov; 97(11):2902-7. PubMed ID: 12425566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survey of the opinions, knowledge, and practices of gastroenterologists regarding colorectal cancer screening and use of the fecal occult blood test.
    Sharma VK; Corder FA; Fancher J; Howden CW
    Am J Gastroenterol; 2000 Dec; 95(12):3629-32. PubMed ID: 11151904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evolving role of CT colonography.
    Deshpande N; Weinberg DS
    Cancer Invest; 2007 Mar; 25(2):127-33. PubMed ID: 17453825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limitations of the faecal occult blood test in screening for colorectal cancer.
    Delcò F; Sonnenberg A
    Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):119-26. PubMed ID: 10363196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of colorectal cancer screening uptake among men and women in the United States.
    Meissner HI; Breen N; Klabunde CN; Vernon SW
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):389-94. PubMed ID: 16492934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effectiveness and cost-effectiveness of screening colonoscopy vs. sigmoidoscopy and alternative strategies.
    Sharaf RN; Ladabaum U
    Am J Gastroenterol; 2013 Jan; 108(1):120-32. PubMed ID: 23247579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of colorectal cancer screening participation in the United States.
    Ioannou GN; Chapko MK; Dominitz JA
    Am J Gastroenterol; 2003 Sep; 98(9):2082-91. PubMed ID: 14499792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal carcinoma screening procedure use among primary care patients.
    Lafata JE; Williams LK; Ben-Menachem T; Moon C; Divine G
    Cancer; 2005 Oct; 104(7):1356-61. PubMed ID: 16092119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of colorectal cancer screening with computed tomography colonography or fecal blood tests.
    Heresbach D; Chauvin P; Grolier J; Josselin JM
    Eur J Gastroenterol Hepatol; 2010 Nov; 22(11):1372-9. PubMed ID: 20802341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The case for population-based screening for colorectal cancer.
    Schoen RE
    Nat Rev Cancer; 2002 Jan; 2(1):65-70. PubMed ID: 11902587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 139.